Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:02 UTC |
---|
HMDB ID | HMDB0015597 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Voacamine |
---|
Description | Voacamine is only found in individuals that have used or taken this drug. It is an alkaloid isolated from the bark of the Pescheria fuchsiae folia tree. It is an antimalarial drug approved for use in several African countries. Voacamine is also under investigation for use in modulating multidrug-resistance in tumor cells. Voacamine is possibly a substrate for P-glycoprotein (P-gp), an efflux pump responsible for multidrug resistance in tumor cells. Voacamine may compete with anticancer drugs such as doxorubicin for P-gp transport, decreasing removal of doxorubicin. |
---|
Structure | [H][C@@]12C[C@H](CC)[C@]3([H])N(C1)CCC1=C(NC4=CC(=C(OC)C=C14)[C@@]1([H])C[C@]4([H])C(C(=O)OC)[C@@]([H])(CC5=C1NC1=CC=CC=C51)N(C)C\C4=C\C)[C@@]3(C2)C(=O)OC InChI=1S/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-/t23-,24-,28-,31+,35+,37?,40-,43+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate | Kegg | Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3a-yl)ibogamine-18-carboxylate | Generator | Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3a-yl)ibogamine-18-carboxylic acid | Generator | Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylic acid | Generator | Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3α-yl)ibogamine-18-carboxylate | Generator | Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3α-yl)ibogamine-18-carboxylic acid | Generator | Voacanginine | HMDB | Vocamine | HMDB |
|
---|
Chemical Formula | C43H52N4O5 |
---|
Average Molecular Weight | 704.8968 |
---|
Monoisotopic Molecular Weight | 704.393770794 |
---|
IUPAC Name | methyl (1S,15S,17S,18S)-17-ethyl-6-[(1R,12R,14R,15E)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate |
---|
Traditional Name | voacamine |
---|
CAS Registry Number | 3371-85-5 |
---|
SMILES | [H][C@@]12C[C@H](CC)[C@]3([H])N(C1)CCC1=C(NC4=CC(=C(OC)C=C14)[C@@]1([H])C[C@]4([H])C(C(=O)OC)[C@@]([H])(CC5=C1NC1=CC=CC=C51)N(C)C\C4=C\C)[C@@]3(C2)C(=O)OC |
---|
InChI Identifier | InChI=1S/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-/t23-,24-,28-,31+,35+,37?,40-,43+/m0/s1 |
---|
InChI Key | VCMIRXRRQJNZJT-XRMSBCOFSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Ibogan-type alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Ibogan-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Ibogan skeleton
- Vobasan skeleton
- Catharanthine skeleton
- Pyrroloazepine
- 3-alkylindole
- Indole
- Indole or derivatives
- Piperidinecarboxylic acid
- Anisole
- Alkyl aryl ether
- Azepine
- Aralkylamine
- Dicarboxylic acid or derivatives
- Piperidine
- Benzenoid
- Pyrrole
- Methyl ester
- Heteroaromatic compound
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Ether
- Amine
- Organic nitrogen compound
- Organic oxide
- Hydrocarbon derivative
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0032 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Voacamine,1TMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([NH]C4=CC=CC=C34)[C@@H](C3=C(OC)C=C4C5=C(N([Si](C)(C)C)C4=C3)[C@]3(C(=O)OC)C[C@@H]4C[C@H](CC)[C@@H]3N(CC5)C4)C[C@@H]1C2C(=O)OC | 5374.3 | Semi standard non polar | 33892256 | Voacamine,1TMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([NH]C4=CC=CC=C34)[C@@H](C3=C(OC)C=C4C5=C(N([Si](C)(C)C)C4=C3)[C@]3(C(=O)OC)C[C@@H]4C[C@H](CC)[C@@H]3N(CC5)C4)C[C@@H]1C2C(=O)OC | 5533.7 | Standard non polar | 33892256 | Voacamine,1TMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([NH]C4=CC=CC=C34)[C@@H](C3=C(OC)C=C4C5=C(N([Si](C)(C)C)C4=C3)[C@]3(C(=O)OC)C[C@@H]4C[C@H](CC)[C@@H]3N(CC5)C4)C[C@@H]1C2C(=O)OC | 7097.3 | Standard polar | 33892256 | Voacamine,1TMS,isomer #2 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C([NH]C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C)C1=CC=CC=C31 | 5363.1 | Semi standard non polar | 33892256 | Voacamine,1TMS,isomer #2 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C([NH]C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C)C1=CC=CC=C31 | 5436.4 | Standard non polar | 33892256 | Voacamine,1TMS,isomer #2 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C([NH]C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C)C1=CC=CC=C31 | 7097.8 | Standard polar | 33892256 | Voacamine,2TMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C(N([Si](C)(C)C)C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C)C1=CC=CC=C31 | 5328.6 | Semi standard non polar | 33892256 | Voacamine,2TMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C(N([Si](C)(C)C)C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C)C1=CC=CC=C31 | 5399.9 | Standard non polar | 33892256 | Voacamine,2TMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C(N([Si](C)(C)C)C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C)C1=CC=CC=C31 | 6784.5 | Standard polar | 33892256 | Voacamine,1TBDMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([NH]C4=CC=CC=C34)[C@@H](C3=C(OC)C=C4C5=C(N([Si](C)(C)C(C)(C)C)C4=C3)[C@]3(C(=O)OC)C[C@@H]4C[C@H](CC)[C@@H]3N(CC5)C4)C[C@@H]1C2C(=O)OC | 5469.7 | Semi standard non polar | 33892256 | Voacamine,1TBDMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([NH]C4=CC=CC=C34)[C@@H](C3=C(OC)C=C4C5=C(N([Si](C)(C)C(C)(C)C)C4=C3)[C@]3(C(=O)OC)C[C@@H]4C[C@H](CC)[C@@H]3N(CC5)C4)C[C@@H]1C2C(=O)OC | 5748.0 | Standard non polar | 33892256 | Voacamine,1TBDMS,isomer #1 | C/C=C1/CN(C)[C@@H]2CC3=C([NH]C4=CC=CC=C34)[C@@H](C3=C(OC)C=C4C5=C(N([Si](C)(C)C(C)(C)C)C4=C3)[C@]3(C(=O)OC)C[C@@H]4C[C@H](CC)[C@@H]3N(CC5)C4)C[C@@H]1C2C(=O)OC | 7111.3 | Standard polar | 33892256 | Voacamine,1TBDMS,isomer #2 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C([NH]C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C31 | 5448.3 | Semi standard non polar | 33892256 | Voacamine,1TBDMS,isomer #2 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C([NH]C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C31 | 5646.4 | Standard non polar | 33892256 | Voacamine,1TBDMS,isomer #2 | C/C=C1/CN(C)[C@@H]2CC3=C([C@@H](C4=C(OC)C=C5C6=C([NH]C5=C4)[C@]4(C(=O)OC)C[C@@H]5C[C@H](CC)[C@@H]4N(CC6)C5)C[C@@H]1C2C(=O)OC)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C31 | 7113.5 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 10V, Positive-QTOF | splash10-0ab9-0000009500-a1a64a21f7d9ec3401fa | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 20V, Positive-QTOF | splash10-05g1-0001009100-2b2d3c299d1d143b7473 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 40V, Positive-QTOF | splash10-03dr-0000039000-9017d6876d59e4847db3 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 10V, Negative-QTOF | splash10-0udi-0000004900-deceec71058f12cd75d0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 20V, Negative-QTOF | splash10-0udr-0002009300-7d3cb4a2a467e2e222ed | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 40V, Negative-QTOF | splash10-052r-0013009000-b8e009201a2611beca79 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 10V, Positive-QTOF | splash10-0a4i-0000001900-a9bca08aaa1c9c199d22 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 20V, Positive-QTOF | splash10-0ab9-0000019700-071162b147ec0628021b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 40V, Positive-QTOF | splash10-00nr-0321049100-e73ebc22ad6ded604e04 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 10V, Negative-QTOF | splash10-0udi-0000003900-5c5f5379323417f95320 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 20V, Negative-QTOF | splash10-0udi-0000009700-41648dc058d6eac61119 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Voacamine 40V, Negative-QTOF | splash10-0550-0014097100-263458458d07d8a975a4 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB04877 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB04877 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB04877 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | C00001785 |
---|
Chemspider ID | 10128230 |
---|
KEGG Compound ID | C09252 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Voacamine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 11953931 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Meschini S, Marra M, Condello M, Calcabrini A, Federici E, Dupuis ML, Cianfriglia M, Arancia G: Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. Int J Oncol. 2005 Dec;27(6):1597-603. [PubMed:16273216 ]
- Meschini S, Marra M, Calcabrini A, Federici E, Galeffi C, Arancia G: Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells. Int J Oncol. 2003 Dec;23(6):1505-13. [PubMed:14612920 ]
- Meschini S, Condello M, Marra M, Formisano G, Federici E, Arancia G: Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells. Toxicol In Vitro. 2007 Mar;21(2):197-203. Epub 2006 Sep 16. [PubMed:17070665 ]
|
---|